性的機能不全薬のアジア市場：市場規模・シェア・価格・動向・予測

• 英文タイトル：Asia Pacific Sexual Dysfunction Drugs Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

• レポートコード：D0FB0630467 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥435,000 (USD3,000)	▷ お問い合わせ
Site License	￥551,000 (USD3,800)	▷ お問い合わせ
Global Site License	￥725,000 (USD5,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

性的機能不全薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は性的機能不全薬の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける性的機能不全薬市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・性的機能不全薬のアジア市場規模推移2014-2019 ・性的機能不全薬のアジア市場規模予測2019-2024 ・性的機能不全薬のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（Pfizer、GlaxoSmithKline、Merck、Eli Lilly、AbbVie、Bayer、Teva Pharmaceutical Industries、Takeda、Apricus Biosciences、Emotional Brain、Ivix LLX、Leadiant Biosciences、NexMed、S1 Biopharma、Vietstar B） ・結論

Abstract:

The Asia Pacific Sexual Dysfunction Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.

This report is an essential reference for who looks for detailed information on Asia Pacific Sexual Dysfunction Drugs market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Sexual Dysfunction Drugs market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.

Key Points of this Report:

* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Sexual Dysfunction Drugs
* It describes present situation, historical background and future forecast
* Comprehensive data showing Sexual Dysfunction Drugs capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Sexual Dysfunction Drugs manufacturers
* Sexual Dysfunction Drugs market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us

The largest vendors of Asia Pacific Sexual Dysfunction Drugs market: (At least 15 companies included)
* Pfizer
* GlaxoSmithKline
* Merck
* Eli Lilly
* AbbVie
* Bayer
For complete list, please ask for sample pages.

The Sexual Dysfunction Drugs market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand

The reports analysis Sexual Dysfunction Drugs market in Asia Pacific by products type:
* Type I
* Type II
* Type III

The reports analysis Sexual Dysfunction Drugs market in Asia Pacific by application as well:
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

---

Table of Contents

Chapter One Sexual Dysfunction Drugs Overview
1.1 Sexual Dysfunction Drugs Outline
1.2 Classification and Application
1.3 Manufacturing Technology

Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis

Chapter Three Market Dynamics of Sexual Dysfunction Drugs Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges

Chapter Four Asia Pacific Market of Sexual Dysfunction Drugs (2014-2019)
4.1 Sexual Dysfunction Drugs Supply
4.2 Sexual Dysfunction Drugs Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis

Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Sexual Dysfunction Drugs Supply
5.2 Sexual Dysfunction Drugs Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis

Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation

Chapter Seven Asia Pacific Sexual Dysfunction Drugs Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis

Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Pfizer
8.2 GlaxoSmithKline
8.3 Merck
8.4 Eli Lilly
8.5 AbbVie
……
……

Chapter Nine Research Conclusions of Asia Pacific Sexual Dysfunction Drugs Industry

Tables and Figures

Figure Commercial Product of Sexual Dysfunction Drugs
Table Classification of Sexual Dysfunction Drugs
Table Application of Sexual Dysfunction Drugs
Figure Porter Five Forces Model Analysis of Asia Pacific Sexual Dysfunction Drugs
Figure Production Cost Analysis of Asia Pacific Sexual Dysfunction Drugs
Table Sexual Dysfunction Drugs Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Capacity List
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production List
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Production Value and Growth Rate
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Sexual Dysfunction Drugs
Table 2014-2019 Asia Pacific Import and Export of Sexual Dysfunction Drugs
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Demand List by Application
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Demand by Application
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Demand Share List by Application
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Demand Share by Application
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption List
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption Share
Table 2014-2019 Asia Pacific Sexual Dysfunction Drugs Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Capacity List
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production List
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Sexual Dysfunction Drugs
Table 2019-2024 Asia Pacific Import and Export of Sexual Dysfunction Drugs
Table 2019-2024 Asia Pacific Demand of Sexual Dysfunction Drugs by Application
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Demand by Application
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Demand Share List by Application
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Demand Share by Application
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption List
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Sexual Dysfunction Drugs Country-wise Consumption Share
Table 2019-2024 Asia Pacific Sexual Dysfunction Drugs Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Sexual Dysfunction Drugs Raw Material Suppliers
Table Key End Users List
Table Profile of Pfizer
Table SWOT Analysis of Pfizer
Table Pfizer Sexual Dysfunction Drugs Product Specification
Table 2014-2019 Pfizer Sexual Dysfunction Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Pfizer Sexual Dysfunction Drugs Capacity Production and Growth Rate
Figure 2014-2019 Pfizer Sexual Dysfunction Drugs Production Global Market Share
Table SWOT Analysis of GlaxoSmithKline
Figure GlaxoSmithKline Sexual Dysfunction Drugs Products
Table 2014-2019 GlaxoSmithKline Sexual Dysfunction Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 GlaxoSmithKline Sexual Dysfunction Drugs Capacity Production and Growth Rate
Figure 2014-2019 GlaxoSmithKline Sexual Dysfunction Drugs Production Global Market Share
Table SWOT Analysis of Merck
Figure Merck Sexual Dysfunction Drugs Product
Table Merck Sexual Dysfunction Drugs Product Specification
Table 2014-2019 Merck Sexual Dysfunction Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Merck Sexual Dysfunction Drugs Capacity Production and Growth Rate
Figure 2014-2019 Merck Sexual Dysfunction Drugs Production Global Market Share
Table Profile of Eli Lilly
Table SWOT Analysis of Eli Lilly
Figure Eli Lilly Sexual Dysfunction Drugs Product
Table Eli Lilly Sexual Dysfunction Drugs Product Specification
Table 2014-2019 Eli Lilly Sexual Dysfunction Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Eli Lilly Sexual Dysfunction Drugs Capacity Production and Growth Rate
Figure 2014-2019 Eli Lilly Sexual Dysfunction Drugs Production Global Market Share
Table Profile of AbbVie
Table SWOT Analysis of AbbVie
Figure AbbVie Sexual Dysfunction Drugs Product
Table 2014-2019 AbbVie Sexual Dysfunction Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 AbbVie Sexual Dysfunction Drugs Capacity Production and Growth Rate
Figure 2014-2019 AbbVie Sexual Dysfunction Drugs Production Global Market Share
……
……

---